Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure

Abroad (travel likely)RecruitingPHASE2

Conditions

Diffuse Large B-Cell Lymphoma · High-grade B-cell Lymphoma (HGBCL) · B-Cell Lymphoma Treatment · Relapsed or Refractory Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations